MERCK Kommanditgesellschaft auf Aktien
MER
Classifica tra le azioni
#323
Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the... Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the healthcare, life science, and electronics sectors. The company is actively involved in the research, development, production, and commercialization of both pharmaceutical and biological prescription medications. These treatments target a range of medical conditions, including those in neurology, immunology, oncology, fertility, and cardiometabolic and endocrine disorders. Furthermore, its life science division furnishes essential products, instruments, and services to support research facilities, pharmaceutical and biotechnology manufacturing, and industrial as well as analytical testing laboratories. Within its electronics segment, MERCK supplies crucial materials for integrated circuits, liquid crystals, organic light-emitting diodes (OLEDs), photoresists, smart antenna systems, and liquid crystal glazing solutions. It also produces specialized effect pigments extensively utilized in applications such as automotive coatings, cosmetics, and various industrial and plastics manufacturing. MERCK maintains strategic partnerships with Pfizer Inc., has an agreement with Novartis AG, and holds license arrangements with Debiopharm International SA and MoonLake Immunotherapeutics AG. Established in 1668, the firm's headquarters are located in Darmstadt, Germany, and it operates as a subsidiary of E. Merck Kommanditgesellschaft.
Prezzo delle azioni
$171.67
Ultima sincronizzazione: 2026-07-13
Capitalizzazione di mercato
$74.64B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-
Paese
DE
Scambia MERCK Kommanditgesellschaft auf Aktien (MER)
Categoria
Healthcare
Rapporto P/S per MERCK Kommanditgesellschaft auf Aktien (MER)
Rapporto P/S al October 2026 TTM: 2.82
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di MERCK Kommanditgesellschaft auf Aktien, il rapporto P/S attuale (TTM) è 2.82. Alla fine del 2024, era pari a 2.88.
Storico del rapporto P/S per MERCK Kommanditgesellschaft auf Aktien da 2002 a 2026
Rapporto P/S alla fine di ogni anno
| Anno | Rapporto P/S | Cambia |
|---|---|---|
| 2026 (TTM) | 2.82 | 11.30% |
| 2025 | 2.53 | -12.14% |
| 2024 | 2.88 | -3.66% |
| 2023 | 2.98 | -15.64% |
| 2022 | 3.54 | -29.43% |
| 2021 | 5.01 | 44.05% |
| 2020 | 3.48 | 22.72% |
| 2019 | 2.84 | 7.07% |
| 2018 | 2.65 | -1.72% |
| 2017 | 2.69 | -6.00% |
| 2016 | 2.87 | -5.44% |
| 2015 | 3.03 | 0.97% |
| 2014 | 3.00 | 17.86% |
| 2013 | 2.55 | 29.16% |
| 2012 | 1.97 | 21.03% |
| 2011 | 1.63 | 16.38% |
| 2010 | 1.40 | -23.42% |
| 2009 | 1.83 | -1.47% |
| 2008 | 1.86 | -30.62% |
| 2007 | 2.68 | -21.82% |
| 2006 | 3.42 | 45.71% |
| 2005 | 2.35 | 30.65% |
| 2004 | 1.80 | 117.02% |
| 2003 | 0.83 | 40.33% |
| 2002 | 0.59 | 0.00% |
Rapporto P/S per aziende simili o concorrenti
| Azienda | Rapporto P/S | Differenza del rapporto P/S | Il paese |
|---|---|---|---|
| 3.02 | 7.17% |
DE
|
|
| 2.19 | -22.34% |
JP
|
|
| 8.92 | 216.80% |
CH
|
|
| 7.06 | 150.64% |
IN
|
|
| 9.37 | 232.68% |
CN
|
